Most patients with newly diagnosed rheumatoid arthritis can successfully discontinue glucocorticoids after short-term ...
Radiation bridging therapy during CAR T-cell manufacturing improves outcomes in R/R LBCL compared to systemic bridging therapy. Axi-cel shows superior overall and complete response rates compared to ...
The interim analysis of a first-in-human phase 1 trial of ET-901, a CRISPR edited allogeneic immune-cloaked anti-CD19 CAR-T cell therapy in patients with r/r B-NHL. This is an ASCO Meeting Abstract ...
Am J Health Syst Pharm. 2011;68(1):36-42. © 2011 American Society of Health-System Pharmacists, Inc. a IPC = intermittent pneumatic compression, VTE = venous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results